Literature DB >> 27076226

Right atrial emptying fraction non-invasively predicts mortality in pulmonary hypertension.

Konstadina Darsaklis1, Matthew E Dickson2, William Cornwell2, Colby R Ayers3, Fernando Torres2, Kelly M Chin2, Susan Matulevicius4.   

Abstract

Right-sided heart failure is the most common cause of death in pulmonary hypertension (PH). Echocardiographic measurements of right atrial (RA) size are associated with worse outcome in PH, however the association between RA function and death in PH has not been well-described. 160 PH patients (World Health Organization groups 1-5) underwent cardiac magnetic resonance imaging (cMRI) and right heart catheterization (RHC) within 6 weeks of each other at a tertiary care academic medical center in the United States. We measured cMRI RA maximum and minimum volumes indexed to body surface area and calculated RA emptying fraction (RAEF). We evaluated the relationship between RAEF and clinical variables with death using Cox proportional hazard models. 57 deaths occurred during a median follow-up of 3.5 years (36 % died overall, 10 % per year). RAEF was directly correlated in univariate analyses with right ventricular (RV) ejection fraction, left ventricular (LV) ejection fraction, LV size, cardiac index, absence of tricuspid and pulmonic regurgitation, absence of pericardial effusion, estimated glomerular filtration rate, 6-minute walk distance, and pulmonary arterial oxygen saturation, whereas it was inversely correlated with death, BNP, heart rate, mean RA pressure, mean PA pressure, pulmonary and systemic vascular resistance, RV size, and RA size. Using multivariate analyses, RAEF had a robust inverse association with death after adjusting for measured risk factors (HR per 5 % change in RAEF: 0.83 [95 % CI 0.73-0.94], p = 0.003). In PH patients, decreased RAEF by cMRI is independently associated with worse survival after adjustment for other risk factors.

Entities:  

Keywords:  Atrium; Magnetic resonance imaging; Pulmonary heart disease; Right heart failure

Mesh:

Year:  2016        PMID: 27076226     DOI: 10.1007/s10554-016-0883-3

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  37 in total

1.  Prognostic utility of right atrial emptying fractions in pulmonary arterial hypertension.

Authors:  Nathan W Brunner; Francois Haddad; Yukari Kobayashi; Andrew Hsi; John R Swiston; Kenneth G Gin; Roham T Zamanian
Journal:  Pulm Circ       Date:  2015-09       Impact factor: 3.017

2.  Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension.

Authors:  Serge A van Wolferen; Johannes T Marcus; Anco Boonstra; Koen M J Marques; Jean G F Bronzwaer; Marieke D Spreeuwenberg; Pieter E Postmus; Anton Vonk-Noordegraaf
Journal:  Eur Heart J       Date:  2007-01-22       Impact factor: 29.983

3.  Sensitive cardiac troponin I predicts poor outcomes in pulmonary arterial hypertension.

Authors:  G A Heresi; W H W Tang; M Aytekin; J Hammel; S L Hazen; R A Dweik
Journal:  Eur Respir J       Date:  2011-09-01       Impact factor: 16.671

4.  Tricuspid annular displacement predicts survival in pulmonary hypertension.

Authors:  Paul R Forfia; Micah R Fisher; Stephen C Mathai; Traci Housten-Harris; Anna R Hemnes; Barry A Borlaug; Elzbieta Chamera; Mary C Corretti; Hunter C Champion; Theodore P Abraham; Reda E Girgis; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2006-08-03       Impact factor: 21.405

5.  Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy.

Authors:  Mariëlle C van de Veerdonk; Taco Kind; J Tim Marcus; Gert-Jan Mauritz; Martijn W Heymans; Harm-Jan Bogaard; Anco Boonstra; Koen M J Marques; Nico Westerhof; Anton Vonk-Noordegraaf
Journal:  J Am Coll Cardiol       Date:  2011-12-06       Impact factor: 24.094

6.  Association of cardiac troponin I with disease severity and outcomes in patients with pulmonary hypertension.

Authors:  Mariella Vélez-Martínez; Colby Ayers; Joseph D Mishkin; Sonja B Bartolome; Christine K García; Fernando Torres; Mark H Drazner; James A de Lemos; Aslan T Turer; Kelly M Chin
Journal:  Am J Cardiol       Date:  2013-03-27       Impact factor: 2.778

7.  Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension.

Authors:  Ronald J Raymond; Alan L Hinderliter; Park W Willis; David Ralph; Edgar J Caldwell; William Williams; Neil A Ettinger; Nicholas S Hill; Warren R Summer; Bennett de Boisblanc; Todd Schwartz; Gary Koch; Linda M Clayton; Maria M Jöbsis; James W Crow; Walker Long
Journal:  J Am Coll Cardiol       Date:  2002-04-03       Impact factor: 24.094

8.  Right Heart Score for Predicting Outcome in Idiopathic, Familial, or Drug- and Toxin-Associated Pulmonary Arterial Hypertension.

Authors:  François Haddad; Onno A Spruijt; Andre Y Denault; Olaf Mercier; Nathan Brunner; David Furman; Elie Fadel; Harm J Bogaard; Ingela Schnittger; Bojan Vrtovec; Joseph C Wu; Vinicio de Jesus Perez; Anton Vonk-Noordegraaf; Roham T Zamanian
Journal:  JACC Cardiovasc Imaging       Date:  2015-05-14

Review 9.  Prostanoid therapy for pulmonary arterial hypertension.

Authors:  David B Badesch; Vallerie V McLaughlin; Marion Delcroix; Carmine Dario Vizza; Horst Olschewski; Olivier Sitbon; Robyn J Barst
Journal:  J Am Coll Cardiol       Date:  2004-06-16       Impact factor: 24.094

10.  Changes in exercise haemodynamics during treatment in pulmonary arterial hypertension.

Authors:  S Provencher; P Hervé; O Sitbon; M Humbert; G Simonneau; D Chemla
Journal:  Eur Respir J       Date:  2008-04-16       Impact factor: 16.671

View more
  7 in total

1.  Right atrial structure and function in patients with hypertension and with chronic heart failure.

Authors:  Moritz Proplesch; Allison A Merz; Brian L Claggett; Eldrin F Lewis; Kristin H Dwyer; Daniela R Crousillat; Emily S Lau; Montane B Silverman; Julie Peck; Jose Rivero; Susan Cheng; Elke Platz
Journal:  Echocardiography       Date:  2018-03-30       Impact factor: 1.724

2.  Reference value of left and right atrial size and phasic function by SSFP CMR at 3.0 T in healthy Chinese adults.

Authors:  Weihao Li; Ke Wan; Yuchi Han; Hong Liu; Wei Cheng; Jiayu Sun; Yong Luo; Dan Yang; Yiu-Cho Chung; Yucheng Chen
Journal:  Sci Rep       Date:  2017-06-09       Impact factor: 4.379

3.  Increased right atrial volume measured with cardiac magnetic resonance is associated with worse clinical outcome in patients with pre-capillary pulmonary hypertension.

Authors:  Anna Bredfelt; Göran Rådegran; Roger Hesselstrand; Håkan Arheden; Ellen Ostenfeld
Journal:  ESC Heart Fail       Date:  2018-06-19

4.  A machine learning cardiac magnetic resonance approach to extract disease features and automate pulmonary arterial hypertension diagnosis.

Authors:  Andrew J Swift; Haiping Lu; Johanna Uthoff; Pankaj Garg; Marcella Cogliano; Jonathan Taylor; Peter Metherall; Shuo Zhou; Christopher S Johns; Samer Alabed; Robin A Condliffe; Allan Lawrie; Jim M Wild; David G Kiely
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2021-01-22       Impact factor: 6.875

5.  Imaging and Risk Stratification in Pulmonary Arterial Hypertension: Time to Include Right Ventricular Assessment.

Authors:  Faisal Alandejani; Abdul Hameed; Euan Tubman; Samer Alabed; Yousef Shahin; Robert A Lewis; Krit Dwivedi; Aqeeb Mahmood; Jennifer Middleton; Lisa Watson; Dheyaa Alkhanfar; Christopher S Johns; Smitha Rajaram; Pankaj Garg; Robin Condliffe; Charlie A Elliot; A A Roger Thompson; Alexander M K Rothman; Athanasios Charalampopoulos; Allan Lawrie; Jim M Wild; Andrew J Swift; David G Kiely
Journal:  Front Cardiovasc Med       Date:  2022-03-25

6.  Risk assessment in PAH using quantitative CMR tricuspid regurgitation: relation to heart catheterization.

Authors:  Erik Hedström; Anna Bredfelt; Göran Rådegran; Håkan Arheden; Ellen Ostenfeld
Journal:  ESC Heart Fail       Date:  2020-05-06

7.  Role of biomarkers in evaluation, treatment and clinical studies of pulmonary arterial hypertension.

Authors:  Anna Hemnes; Alexander M K Rothman; Andrew J Swift; Lawrence S Zisman
Journal:  Pulm Circ       Date:  2020-11-18       Impact factor: 2.886

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.